Latest opioid-induced constipation Stories
LAVAL, Quebec and TARRYTOWN, N.Y., April 24, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc.
WILMINGTON, Del., March 31, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca announced today that MOVANTIK(TM) (naloxegol) has launched in the United States.
FLORHAM PARK, N.J., March 30, 2015 /PRNewswire/ -- Naldemedine, an investigational peripherally acting mu-opioid receptor antagonist (PAMORA) under development by Shionogi & Co., Ltd., met
First-in-class treatment approved for adult patients with opioid-induced constipation who have had an inadequate response to laxatives SAN FRANCISCO, Dec.
Studies to Investigate Ability of KP201 to Deter Abuse and Reduce Opioid-Induced Constipation CORALVILLE, Iowa, Sept.
SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published
LONDON, June 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal Phase III studies - KODIAC-4 and KODIAC-5
SAN FRANCISCO, June 12, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca announced that the majority of US Food and Drug Administration (FDA) Anesthetic
Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help.
- An armed gangster.